-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vera Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
- Vera Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$37.3M, a 70% decline year-over-year.
- Vera Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$117M, a 4.63% decline year-over-year.
- Vera Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$102M, a 12.2% decline from 2022.
- Vera Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$90.9M, a 164% decline from 2021.
- Vera Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$34.4M, a 34.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)